£82.73

Springer Regulating Pharmaceutical Prices in India: Policy Design, Implementation and Compliance (India Studies in Business and Economics)

Price data last checked 57 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 34 days • 34 data points (No recent data available)

Historical
Generating forecast...
£83.59 £80.65 £81.29 £81.93 £82.58 £83.22 £83.86 25 January 2026 02 February 2026 10 February 2026 18 February 2026 27 February 2026

Price Distribution

Price distribution over 34 days • 3 price levels

Days at Price
Current Price
9 days 3 days · current 22 days 0 6 11 17 22 £81 £83 £84 Days at Price

Price Analysis

Most common price: £84 (22 days, 64.7%)

Price range: £81 - £84

Price levels: 3 different prices over 34 days

Description

Product Description This book presents an extensive study on the effectiveness of recent regulations on pharmaceutical prices in India, exploring the weaknesses in the design and implementation of pharmaceutical price controls and investigating what can be done to fix the broken system. In addition, it examines the extent to which essential medicines are actually made affordable by price controls. The book argues that companies make the pharmaceutical price control regime largely ineffective by coordinating to increase pre-regulation prices; by diversifying horizontally away from the regulated markets and increasing prices in the unregulated markets; by manipulating trade margins; and by refusing to comply with the regulation because the penalties remains negligible. The book draws on extensive empirical research involving India’s 2013 Drug Price Control Order and widely-used medicines such as paracetamol and metformin to illustrate how firms have weakened regulation. It argues that the regulatory regime can be strengthened by using systematic analysis of product- and region-level data in the Indian pharmaceutical industry, and by screening for the strategies that firms currently employ to circumvent regulation. In closing, it discusses recent efforts to strengthen the implementation of price controls in India and expanding the scope of price controls to medical devices. From the Back Cover This book presents an extensive study on the effectiveness of recent regulations on pharmaceutical prices in India, exploring the weaknesses in the design and implementation of pharmaceutical price controls and investigating what can be done to fix the broken system. In addition, it examines the extent to which essential medicines are actually made affordable by price controls. The book argues that companies make the pharmaceutical price control regime largely ineffective by coordinating to increase pre-regulation prices; by diversifying horizontally away from the regulated markets and increasing prices in the unregulated markets; by manipulating trade margins; and by refusing to comply with the regulation because the penalties remains negligible. The book draws on extensive empirical research involving India’s 2013 Drug Price Control Order and widely-used medicines such as paracetamol and metformin to illustrate how firms have weakened regulation. It argues that the regulatory regime can be strengthened by using systematic analysis of product- and region-level data in the Indian pharmaceutical industry, and by screening for the strategies that firms currently employ to circumvent regulation. In closing, it discusses recent efforts to strengthen the implementation of price controls in India and expanding the scope of price controls to medical devices. About the Author Ajay Bhaskarabhatla is an associate professor at Erasmus School of Economics, The Netherlands. Ajay’s research on the Indian pharmaceutical industry has been published in top peer-reviewed journals.

Product Specifications

Format
Paperback
Domain
Amazon UK
Release Date
30 January 2019
Listed Since
30 January 2019

Barcode

No barcode data available

Similar Products You Might Like

Regulating Pharmaceutical Prices in India: Policy Design, Implementation and Compliance (India Studies in Business and Economics)
100% match

Regulating Pharmaceutical Prices in India: Policy Design, Implementation and Compliance (India Studies in Business and Economics)

Springer

£82.91 08 Feb 2026
Formulating and Implementing Pharmaceutical Pricing Policies: Challenges, Case Studies and Lessons Learned from Medicine Price Control
94% match

Formulating and Implementing Pharmaceutical Pricing Policies: Challenges, Case Studies and Lessons Learned from Medicine Price Control

£121.68 12 Jan 2026
Routledge Pharmaceutical Industry and Public Policy in India
93% match

Routledge Pharmaceutical Industry and Public Policy in India

Routledge

£125.00 20 Apr 2026
Market, Regulations and Finance: Global Meltdown and the Indian Economy (India Studies in Business and Economics)
93% match

Market, Regulations and Finance: Global Meltdown and the Indian Economy (India Studies in Business and Economics)

Springer

£73.85 08 Mar 2026
Edward Elgar - Intellectual Property, Pharmaceuticals and Public Health
93% match

Edward Elgar - Intellectual Property, Pharmaceuticals and Public Health

Edward Elgar Publishing

£92.14 19 Apr 2026
The Global Pharmaceutical Industry: The Demise and the Path to Recovery (Routledge Advances in Management and Business Studies)
93% match

The Global Pharmaceutical Industry: The Demise and the Path to Recovery (Routledge Advances in Management and Business Studies)

Routledge

£137.61 24 Mar 2026
Medicine Price Surveys, Analyses and Comparisons: Evidence and Methodology Guidance
93% match

Medicine Price Surveys, Analyses and Comparisons: Evidence and Methodology Guidance

Academic Press

£99.59 02 Mar 2026
Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry
93% match

Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry

MACMILLAN

£80.65 08 Feb 2026
Agro and Food Processing Industry in India: Inter-sectoral Linkages, Employment, Productivity and Competitiveness (India Studies in Business and Economics)
93% match

Agro and Food Processing Industry in India: Inter-sectoral Linkages, Employment, Productivity and Competitiveness (India Studies in Business and Economics)

Springer

£82.14 22 Feb 2026
CRC Press - Government, Big Pharma, and The People Book
93% match

CRC Press - Government, Big Pharma, and The People Book

CRC Press

£112.71 04 Mar 2026
Government, Big Pharma, and The People: A Century of Dis-Ease
92% match

Government, Big Pharma, and The People: A Century of Dis-Ease

CRC Press

£49.99 22 Feb 2026
Performance of Pharmaceutical Companies in India: A Critical Analysis of Industrial Structure, Firm Specific Resources, and Emerging Strategies (Contributions to Economics)
92% match

Performance of Pharmaceutical Companies in India: A Critical Analysis of Industrial Structure, Firm Specific Resources, and Emerging Strategies (Contributions to Economics)

Physica

£76.14 13 Apr 2026
Immunotherapy – A Novel Facet of Modern Therapeutics
92% match

Immunotherapy – A Novel Facet of Modern Therapeutics

Springer

£116.33 08 Mar 2026
Immunotherapy – A Novel Facet of Modern Therapeutics
92% match

Immunotherapy – A Novel Facet of Modern Therapeutics

Springer

£90.13 23 Feb 2026
Agricultural Growth and Rural Poverty Reduction in India: Targeting Investments and Input Subsidies (India Studies in Business and Economics)
92% match

Agricultural Growth and Rural Poverty Reduction in India: Targeting Investments and Input Subsidies (India Studies in Business and Economics)

Springer

£75.31 07 Mar 2026
Indian Economy: Reforms and Development: Essays in Honour of Manoj Kumar Sanyal (India Studies in Business and Economics)
92% match

Indian Economy: Reforms and Development: Essays in Honour of Manoj Kumar Sanyal (India Studies in Business and Economics)

Springer

£75.84 08 Mar 2026
Pharmaceutical Public Policy
92% match

Pharmaceutical Public Policy

CRC Press

£58.11 07 Mar 2026
PHARMACEUTICAL ECONOMICS AND POLICY 3RD EDITION: Perspectives, Promises, and Problems
92% match

PHARMACEUTICAL ECONOMICS AND POLICY 3RD EDITION: Perspectives, Promises, and Problems

Oxford University Press

£65.63 02 Feb 2026
Monetary Policy in India: A Modern Macroeconomic Perspective
92% match

Monetary Policy in India: A Modern Macroeconomic Perspective

Springer

£147.58 10 Feb 2026
Low Carbon Pathways for Growth in India (India Studies in Business and Economics)
92% match

Low Carbon Pathways for Growth in India (India Studies in Business and Economics)

Springer

£81.07 21 Feb 2026
Low Carbon Pathways for Growth in India (India Studies in Business and Economics)
92% match

Low Carbon Pathways for Growth in India (India Studies in Business and Economics)

Springer

£83.58 22 Feb 2026
Springer - Excessive Pricing and Competition Law Enforcement
92% match

Springer - Excessive Pricing and Competition Law Enforcement

Springer

£122.93 26 Feb 2026
Global Pharmaceutical Policy: Ensuring Medicines for Tomorrow’s World
92% match

Global Pharmaceutical Policy: Ensuring Medicines for Tomorrow’s World

Edward Elgar Publishing

£31.81 30 Mar 2026
The Law and Ethics of the Pharmaceutical Industry
92% match

The Law and Ethics of the Pharmaceutical Industry

Elsevier

£40.65 13 Jan 2026